Business · 02/05/1997
FDA Publishes Draft Guideline on Timing of Nonclinical Studies for Human Clinical Trials
The FDA is releasing a draft guideline to establish international standards for nonclinical safety studies needed to support human clinical trials of pharmaceuticals, in collaboration with the International Conference on Harmonisation.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →